HB 377-FN - AS AMENDED BY THE HOUSE
27Mar2025... 1083h
2025 SESSION
25-0436
11/05
HOUSE BILL 377-FN
AN ACT relative to health care professionals administering hormone treatments and puberty blockers.
SPONSORS: Rep. Mazur, Hills. 44; Rep. Kofalt, Hills. 32; Rep. Layon, Rock. 13; Rep. Reinfurt, Hills. 29; Rep. Seidel, Hills. 29; Rep. Litchfield, Rock. 32; Rep. J. Aron, Sull. 4; Rep. DeVito, Rock. 8; Rep. Peternel, Carr. 6; Sen. Murphy, Dist 16
COMMITTEE: Health, Human Services and Elderly Affairs
-----------------------------------------------------------------
AMENDED ANALYSIS
This bill prohibits the performance of a medical procedure or the prescription or issuance of medication, upon or to a minor child, that is intended to alter the minor child's gender or delay puberty. This bill also provides for a limited period in which a health care provider may systematically reduce or taper puberty-blocking or cross-sex hormone medications or drugs to avoid harm to a minor already receiving treatment.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Explanation: Matter added to current law appears in bold italics.
Matter removed from current law appears [in brackets and struckthrough.]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
27Mar2025... 1083h 25-0436
11/05
STATE OF NEW HAMPSHIRE
In the Year of Our Lord Two Thousand Twenty Five
AN ACT relative to health care professionals administering hormone treatments and puberty blockers.
Be it Enacted by the Senate and House of Representatives in General Court convened:
1 Short Title. This act shall be known as the Vulnerable Child Compassion and Protection Act.
2 New Chapter; Prohibiting Medical Procedures and Treatments Intended to Alter a Minor's Gender or Puberty. Amend RSA by inserting after chapter 332-M the following new chapter:
CHAPTER 332-N
PROHIBITING MEDICAL PROCEDURES AND TREATMENTS INTENDED TO ALTER A MINOR'S GENDER OR PUBERTY
332-N:1 Definitions. As used in this chapter:
I. "Biological sex" shall mean the male and female biological sexes.
II. "Minor" means a person under 18 years of age.
III. "Person" includes any of the following:
(a) Any individual.
(b) Any agent, employee, official, or contractor of any legal entity.
(c) Any agent, employee, official, or contractor of a school district or the state or any of its political subdivisions or agencies.
332-N:2 Prohibitions for Health Care Providers.
I. Except as provided in paragraphs II and III, a person shall not knowingly perform or offer to perform on a minor, or administer or offer to administer to a minor, a medical procedure, including but not limited to a puberty-blocking or cross-sex hormone medication, if the performance or administration of the procedure or medication is for the purpose of altering or attempting to alter the appearance of or affirm the minor's perception of his or her gender or sex, if that perception is inconsistent with the minor's biological sex as defined in this chapter:
(a) Enabling a minor to identify with, or live as, a purported identity inconsistent with the minor's biological sex; or
(b) Treating purported discomfort or distress from a discordance between the minor's biological sex and asserted identity.
II. Paragraph I shall not apply to a procedure undertaken to treat a minor born with a medically verifiable disorder of sex development as defined in RSA 332-M:2, II.
III. Paragraph I shall not apply to a health care provider who, having prescribed a course of treatment to a minor prior to the effective date of this section that includes the delivery or administration of puberty-blocking or cross-sex hormone medications, determines and documents in the minor's medical record that immediate termination of the minor's use of the puberty-blocking or cross-sex hormone medications or drugs would cause harm to the minor, and institutes a systematic reduction or tapering of puberty-blocking or cross-sex hormone medications or drugs that shall conclude prior to January 1, 2026.
IV. A violation of this section is a class B felony.
3 Prospective Repeal. RSA 332-N:2, III, relative to systematic reduction and tapering of puberty-blocking or cross-sex hormone medications, is repealed.
I. Section 3 of this act shall take effect January 1, 2026.
II. The remainder of this act shall take effect upon its passage.
25-0436
12/11/24
HB 377-FN- FISCAL NOTE
AS INTRODUCED
FISCAL IMPACT:
|
| |||||
Estimated State Impact | ||||||
| FY 2025 | FY 026 | FY 2027 | FY 2028 | ||
Revenue | $0 | $0 | $0 | $0 | ||
Revenue Fund | None | |||||
Expenditures* | Indeterminable | |||||
Funding Source | General Fund | |||||
Appropriations* | $0 | $0 | $0 | $0 | ||
Funding Source | None | |||||
*Expenditure = Cost of bill *Appropriation = Authorized funding to cover cost of bill | ||||||
| ||||||
Estimated Political Subdivision Impact | ||||||
| FY 2025 | FY 2026 | FY 2027 | FY 2028 | ||
County Revenue | $0 | $0 | $0 | $0 | ||
County Expenditures | Indeterminable | |||||
Local Revenue | $0 | $0 | $0 | $0 | ||
Local Expenditures | Indeterminable | |||||
METHODOLOGY:
This bill adds, deletes, or modifies a criminal penalty, or changes statute to which there is a penalty for violation. Therefore, this bill may have an impact on the judicial and correctional systems, which could affect prosecution, incarceration, probation, and parole costs, for the state, as well as county and local governments. A summary of such costs can be found at: https://gencourt.state.nh.us/lba/Budget/Fiscal_Notes/JudicialCorrectionalCosts.pdf
AGENCIES CONTACTED:
Judicial Branch, Judicial Council, Department of Justice, Department of Corrections, New Hampshire Association of Counties, and New Hampshire Municipal Association